Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2019-20 Influenza Season.

Grohskopf LA, Alyanak E, Broder KR, Walter EB, Fry AM, Jernigan DB.

MMWR Recomm Rep. 2019 Aug 23;68(3):1-21. doi: 10.15585/mmwr.rr6803a1.

2.

Historical and clinical aspects of the 1918 H1N1 pandemic in the United States.

Jester B, Uyeki TM, Jernigan DB, Tumpey TM.

Virology. 2019 Jan 15;527:32-37. doi: 10.1016/j.virol.2018.10.019. Epub 2018 Nov 16. Review.

PMID:
30453209
3.

100 Years of Medical Countermeasures and Pandemic Influenza Preparedness.

Jester BJ, Uyeki TM, Patel A, Koonin L, Jernigan DB.

Am J Public Health. 2018 Nov;108(11):1469-1472. doi: 10.2105/AJPH.2018.304586. Epub 2018 Sep 25.

4.

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices-United States, 2018-19 Influenza Season.

Grohskopf LA, Sokolow LZ, Broder KR, Walter EB, Fry AM, Jernigan DB.

MMWR Recomm Rep. 2018 Aug 24;67(3):1-20. doi: 10.15585/mmwr.rr6703a1.

5.

Progress in Vaccine-Preventable and Respiratory Infectious Diseases-First 10 Years of the CDC National Center for Immunization and Respiratory Diseases, 2006-2015.

Schuchat A, Anderson LJ, Rodewald LE, Cox NJ, Hajjeh R, Pallansch MA, Messonnier NE, Jernigan DB, Wharton M.

Emerg Infect Dis. 2018 Jul;24(7):1178-1187. doi: 10.3201/eid2407.171699.

6.

Update: ACIP Recommendations for the Use of Quadrivalent Live Attenuated Influenza Vaccine (LAIV4) - United States, 2018-19 Influenza Season.

Grohskopf LA, Sokolow LZ, Fry AM, Walter EB, Jernigan DB.

MMWR Morb Mortal Wkly Rep. 2018 Jun 8;67(22):643-645. doi: 10.15585/mmwr.mm6722a5.

7.

Systematic Assessment of Multiple Routine and Near Real-Time Indicators to Classify the Severity of Influenza Seasons and Pandemics in the United States, 2003-2004 Through 2015-2016.

Biggerstaff M, Kniss K, Jernigan DB, Brammer L, Bresee J, Garg S, Burns E, Reed C.

Am J Epidemiol. 2018 May 1;187(5):1040-1050. doi: 10.1093/aje/kwx334.

8.

The Global Threat of Animal Influenza Viruses of Zoonotic Concern: Then and Now.

Widdowson MA, Bresee JS, Jernigan DB.

J Infect Dis. 2017 Sep 15;216(suppl_4):S493-S498. doi: 10.1093/infdis/jix331.

PMID:
28934463
9.

Update: Increase in Human Infections with Novel Asian Lineage Avian Influenza A(H7N9) Viruses During the Fifth Epidemic - China, October 1, 2016-August 7, 2017.

Kile JC, Ren R, Liu L, Greene CM, Roguski K, Iuliano AD, Jang Y, Jones J, Thor S, Song Y, Zhou S, Trock SC, Dugan V, Wentworth DE, Levine MZ, Uyeki TM, Katz JM, Jernigan DB, Olsen SJ, Fry AM, Azziz-Baumgartner E, Davis CT.

MMWR Morb Mortal Wkly Rep. 2017 Sep 8;66(35):928-932. doi: 10.15585/mmwr.mm6635a2. Erratum in: MMWR Morb Mortal Wkly Rep. 2017 Oct 13;66(40):1084.

10.

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2017-18 Influenza Season.

Grohskopf LA, Sokolow LZ, Broder KR, Walter EB, Bresee JS, Fry AM, Jernigan DB.

MMWR Recomm Rep. 2017 Aug 25;66(2):1-20. doi: 10.15585/mmwr.rr6602a1.

11.

Novel influenza A viruses and pandemic threats.

Uyeki TM, Katz JM, Jernigan DB.

Lancet. 2017 Jun 3;389(10085):2172-2174. doi: 10.1016/S0140-6736(17)31274-6. No abstract available.

12.

Stockpiled pre-pandemic H5N1 influenza virus vaccines with AS03 adjuvant provide cross-protection from H5N2 clade 2.3.4.4 virus challenge in ferrets.

Sun X, Belser JA, Pulit-Penaloza JA, Creager HM, Guo Z, Jefferson SN, Liu F, York IA, Stevens J, Maines TR, Jernigan DB, Katz JM, Levine MZ, Tumpey TM.

Virology. 2017 Aug;508:164-169. doi: 10.1016/j.virol.2017.05.010. Epub 2017 May 26.

13.

Increase in Human Infections with Avian Influenza A(H7N9) Virus During the Fifth Epidemic - China, October 2016-February 2017.

Iuliano AD, Jang Y, Jones J, Davis CT, Wentworth DE, Uyeki TM, Roguski K, Thompson MG, Gubareva L, Fry AM, Burns E, Trock S, Zhou S, Katz JM, Jernigan DB.

MMWR Morb Mortal Wkly Rep. 2017 Mar 10;66(9):254-255. doi: 10.15585/mmwr.mm6609e2.

14.

Evaluation of multiplex assay platforms for detection of influenza hemagglutinin subtype specific antibody responses.

Li ZN, Weber KM, Limmer RA, Horne BJ, Stevens J, Schwerzmann J, Wrammert J, McCausland M, Phipps AJ, Hancock K, Jernigan DB, Levine M, Katz JM, Miller JD.

J Virol Methods. 2017 May;243:61-67. doi: 10.1016/j.jviromet.2017.01.008. Epub 2017 Jan 17.

PMID:
28108183
15.

CDC Grand Rounds: Modeling and Public Health Decision-Making.

Fischer LS, Santibanez S, Hatchett RJ, Jernigan DB, Meyers LA, Thorpe PG, Meltzer MI.

MMWR Morb Mortal Wkly Rep. 2016 Dec 9;65(48):1374-1377. doi: 10.15585/mmwr.mm6548a4.

16.

Prevention and Control of Seasonal Influenza with Vaccines.

Grohskopf LA, Sokolow LZ, Broder KR, Olsen SJ, Karron RA, Jernigan DB, Bresee JS.

MMWR Recomm Rep. 2016 Aug 26;65(5):1-54. doi: 10.15585/mmwr.rr6505a1.

PMID:
27560619
17.

Overview, Control Strategies, and Lessons Learned in the CDC Response to the 2014-2016 Ebola Epidemic.

Bell BP, Damon IK, Jernigan DB, Kenyon TA, Nichol ST, O'Connor JP, Tappero JW.

MMWR Suppl. 2016 Jul 8;65(3):4-11. doi: 10.15585/mmwr.su6503a2. Review.

PMID:
27389903
18.

H7N9: preparing for the unexpected in influenza.

Jernigan DB, Cox NJ.

Annu Rev Med. 2015;66:361-71. doi: 10.1146/annurev-med-010714-112311. Epub 2014 Oct 29. Review.

PMID:
25386931
19.

Updated preparedness and response framework for influenza pandemics.

Holloway R, Rasmussen SA, Zaza S, Cox NJ, Jernigan DB.

MMWR Recomm Rep. 2014 Sep 26;63(RR-06):1-18.

20.

Response to Al-Husayni and Hassoun.

Uyeki TM, Jernigan DB.

J Clin Virol. 2014 Sep;61(1):176-7. doi: 10.1016/j.jcv.2014.05.016. Epub 2014 Jun 2. No abstract available.

21.

Rapid influenza diagnostic test use and antiviral prescriptions in outpatient settings pre- and post-2009 H1N1 pandemic.

Williams LO, Kupka NJ, Schmaltz SP, Barrett S, Uyeki TM, Jernigan DB.

J Clin Virol. 2014 May;60(1):27-33. doi: 10.1016/j.jcv.2014.01.016. Epub 2014 Feb 12.

PMID:
24630481
22.

Human infections with influenza A(H3N2) variant virus in the United States, 2011-2012.

Epperson S, Jhung M, Richards S, Quinlisk P, Ball L, Moll M, Boulton R, Haddy L, Biggerstaff M, Brammer L, Trock S, Burns E, Gomez T, Wong KK, Katz J, Lindstrom S, Klimov A, Bresee JS, Jernigan DB, Cox N, Finelli L; Influenza A (H3N2)v Virus Investigation Team.

Clin Infect Dis. 2013 Jul;57 Suppl 1:S4-S11. doi: 10.1093/cid/cit272.

PMID:
23794729
23.

Estimates of the number of human infections with influenza A(H3N2) variant virus, United States, August 2011-April 2012.

Biggerstaff M, Reed C, Epperson S, Jhung MA, Gambhir M, Bresee JS, Jernigan DB, Swerdlow DL, Finelli L.

Clin Infect Dis. 2013 Jul;57 Suppl 1:S12-5. doi: 10.1093/cid/cit273.

24.

Progress in global surveillance and response capacity 10 years after severe acute respiratory syndrome.

Braden CR, Dowell SF, Jernigan DB, Hughes JM.

Emerg Infect Dis. 2013 Jun;19(6):864-9. doi: 10.3201/eid1906.130192. Review.

25.

Novel framework for assessing epidemiologic effects of influenza epidemics and pandemics.

Reed C, Biggerstaff M, Finelli L, Koonin LM, Beauvais D, Uzicanin A, Plummer A, Bresee J, Redd SC, Jernigan DB.

Emerg Infect Dis. 2013 Jan;19(1):85-91. doi: 10.3201/eid1901.120124.

26.

Detecting 2009 pandemic influenza A (H1N1) virus infection: availability of diagnostic testing led to rapid pandemic response.

Jernigan DB, Lindstrom SL, Johnson JR, Miller JD, Hoelscher M, Humes R, Shively R, Brammer L, Burke SA, Villanueva JM, Balish A, Uyeki T, Mustaquim D, Bishop A, Handsfield JH, Astles R, Xu X, Klimov AI, Cox NJ, Shaw MW.

Clin Infect Dis. 2011 Jan 1;52 Suppl 1:S36-43. doi: 10.1093/cid/ciq020.

PMID:
21342897
27.

Prevention of community-associated methicillin-resistant Staphylococcus aureus infection among Asian/Pacific Islanders: a qualitative assessment.

Ciccarone RM, Kim M, Tice AD, Nakata M, Effler P, Jernigan DB, Cardo DM, Sinkowitz-Cochran RL.

Hawaii Med J. 2010 Jun;69(6):142-4.

28.

Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans.

Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, Balish A, Sessions WM, Xu X, Skepner E, Deyde V, Okomo-Adhiambo M, Gubareva L, Barnes J, Smith CB, Emery SL, Hillman MJ, Rivailler P, Smagala J, de Graaf M, Burke DF, Fouchier RA, Pappas C, Alpuche-Aranda CM, López-Gatell H, Olivera H, López I, Myers CA, Faix D, Blair PJ, Yu C, Keene KM, Dotson PD Jr, Boxrud D, Sambol AR, Abid SH, St George K, Bannerman T, Moore AL, Stringer DJ, Blevins P, Demmler-Harrison GJ, Ginsberg M, Kriner P, Waterman S, Smole S, Guevara HF, Belongia EA, Clark PA, Beatrice ST, Donis R, Katz J, Finelli L, Bridges CB, Shaw M, Jernigan DB, Uyeki TM, Smith DJ, Klimov AI, Cox NJ.

Science. 2009 Jul 10;325(5937):197-201. doi: 10.1126/science.1176225. Epub 2009 May 22.

29.

National surveillance of emergency department visits for outpatient adverse drug events in children and adolescents.

Cohen AL, Budnitz DS, Weidenbach KN, Jernigan DB, Schroeder TJ, Shehab N, Pollock DA.

J Pediatr. 2008 Mar;152(3):416-21. doi: 10.1016/j.jpeds.2007.07.041. Epub 2007 Oct 22. Erratum in: J Pediatr. 2008 Jun;152(6):893.

PMID:
18280852
30.

Chronic disease and disasters medication demands of Hurricane Katrina evacuees.

Jhung MA, Shehab N, Rohr-Allegrini C, Pollock DA, Sanchez R, Guerra F, Jernigan DB.

Am J Prev Med. 2007 Sep;33(3):207-10.

PMID:
17826580
31.

A multistate outbreak of Serratia marcescens bloodstream infection associated with contaminated intravenous magnesium sulfate from a compounding pharmacy.

Sunenshine RH, Tan ET, Terashita DM, Jensen BJ, Kacica MA, Sickbert-Bennett EE, Noble-Wang JA, Palmieri MJ, Bopp DJ, Jernigan DB, Kazakova S, Bresnitz EA, Tan CG, McDonald LC.

Clin Infect Dis. 2007 Sep 1;45(5):527-33. Epub 2007 Jul 24.

PMID:
17682984
32.

Methicillin-resistant Staphylococcus aureus infections among healthy full-term newborns.

James L, Gorwitz RJ, Jones RC, Watson JT, Hageman JC, Jernigan DB, Lord Y, Caballes N, Cortes C, Golash RG, Price JS, Gerber SI.

Arch Dis Child Fetal Neonatal Ed. 2008 Jan;93(1):F40-4. Epub 2007 Apr 5.

PMID:
17412749
33.

Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization.

Sunenshine RH, Wright MO, Maragakis LL, Harris AD, Song X, Hebden J, Cosgrove SE, Anderson A, Carnell J, Jernigan DB, Kleinbaum DG, Perl TM, Standiford HC, Srinivasan A.

Emerg Infect Dis. 2007 Jan;13(1):97-103.

34.

Staphylococcus aureus-associated skin and soft tissue infections in ambulatory care.

McCaig LF, McDonald LC, Mandal S, Jernigan DB.

Emerg Infect Dis. 2006 Nov;12(11):1715-23.

35.

Emergence of community-associated methicillin resistant Staphylococcus aureus in Hawaii, 2001-2003.

Estivariz CF, Park SY, Hageman JC, Dvorin J, Melish MM, Arpon R, Coon P, Slavish S, Kim M, McDougal LK, Jensen B, McAllister S, Lonsway D, Killgore G, Effler PE, Jernigan DB.

J Infect. 2007 Apr;54(4):349-57. Epub 2006 Sep 20.

PMID:
16989904
36.

Community-associated methicillin-resistant Staphylococcus aureus skin infections in a religious community.

Coronado F, Nicholas JA, Wallace BJ, Kohlerschmidt DJ, Musser K, Schoonmaker-Bopp DJ, Zimmerman SM, Boller AR, Jernigan DB, Kacica MA.

Epidemiol Infect. 2007 Apr;135(3):492-501. Epub 2006 Jul 26.

37.

Emerging infectious disease outbreaks: old lessons and new challenges for obstetrician-gynecologists.

Jamieson DJ, Ellis JE, Jernigan DB, Treadwell TA.

Am J Obstet Gynecol. 2006 Jun;194(6):1546-55. Epub 2006 Apr 21. Review.

PMID:
16731070
38.

Transmission of lymphocytic choriomeningitis virus by organ transplantation.

Fischer SA, Graham MB, Kuehnert MJ, Kotton CN, Srinivasan A, Marty FM, Comer JA, Guarner J, Paddock CD, DeMeo DL, Shieh WJ, Erickson BR, Bandy U, DeMaria A Jr, Davis JP, Delmonico FL, Pavlin B, Likos A, Vincent MJ, Sealy TK, Goldsmith CS, Jernigan DB, Rollin PE, Packard MM, Patel M, Rowland C, Helfand RF, Nichol ST, Fishman JA, Ksiazek T, Zaki SR; LCMV in Transplant Recipients Investigation Team.

N Engl J Med. 2006 May 25;354(21):2235-49.

39.

Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season.

Hageman JC, Uyeki TM, Francis JS, Jernigan DB, Wheeler JG, Bridges CB, Barenkamp SJ, Sievert DM, Srinivasan A, Doherty MC, McDougal LK, Killgore GE, Lopatin UA, Coffman R, MacDonald JK, McAllister SK, Fosheim GE, Patel JB, McDonald LC.

Emerg Infect Dis. 2006 Jun;12(6):894-9.

40.

Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003.

McDonald LC, Owings M, Jernigan DB.

Emerg Infect Dis. 2006 Mar;12(3):409-15.

41.

Emerging infections and pregnancy: West Nile virus, monkeypox, severe acute respiratory syndrome, and bioterrorism.

Jamieson DJ, Jernigan DB, Ellis JE, Treadwell TA.

Clin Perinatol. 2005 Sep;32(3):765-76. Review.

PMID:
16085032
42.

A new old opportunity for preventing serious group A streptococcal infections.

Levine OS, Van Beneden CA, Jernigan DB.

Clin Infect Dis. 2005 Aug 1;41(3):343-4. Epub 2005 Jun 16. No abstract available.

PMID:
16007531
43.

Neonatal sepsis in Egypt associated with bacterial contamination of glucose-containing intravenous fluids.

Moore KL, Kainer MA, Badrawi N, Afifi S, Wasfy M, Bashir M, Jarvis WR, Graham TW, el-Kholy A, Gipson R, Jernigan DB, Mahoney F.

Pediatr Infect Dis J. 2005 Jul;24(7):590-4.

PMID:
15998998
44.

Methicillin-resistant-Staphylococcus aureus hospitalizations, United States.

Kuehnert MJ, Hill HA, Kupronis BA, Tokars JI, Solomon SL, Jernigan DB.

Emerg Infect Dis. 2005 Jun;11(6):868-72. Erratum in: Emerg Infect Dis. 2006 Sep;12(9):1472.

45.

A national survey of severe influenza-associated complications among children and adults, 2003-2004.

Podewils LJ, Liedtke LA, McDonald LC, Hageman JC, Strausbaugh LJ, Fischer TK, Jernigan DB, Uyeki TM, Kuehnert MJ; Infectious Diseases Society of America Emerging Infections Network.

Clin Infect Dis. 2005 Jun 1;40(11):1693-6. Epub 2005 Apr 25.

PMID:
15889371
46.

Transmission of rabies virus from an organ donor to four transplant recipients.

Srinivasan A, Burton EC, Kuehnert MJ, Rupprecht C, Sutker WL, Ksiazek TG, Paddock CD, Guarner J, Shieh WJ, Goldsmith C, Hanlon CA, Zoretic J, Fischbach B, Niezgoda M, El-Feky WH, Orciari L, Sanchez EQ, Likos A, Klintmalm GB, Cardo D, LeDuc J, Chamberland ME, Jernigan DB, Zaki SR; Rabies in Transplant Recipients Investigation Team.

N Engl J Med. 2005 Mar 17;352(11):1103-11.

47.

A clone of methicillin-resistant Staphylococcus aureus among professional football players.

Kazakova SV, Hageman JC, Matava M, Srinivasan A, Phelan L, Garfinkel B, Boo T, McAllister S, Anderson J, Jensen B, Dodson D, Lonsway D, McDougal LK, Arduino M, Fraser VJ, Killgore G, Tenover FC, Cody S, Jernigan DB.

N Engl J Med. 2005 Feb 3;352(5):468-75.

48.

Rapid evaluation of risk of white particulate matter in blood components by a statewide survey of transfusion reactions.

Iwamoto M, Curns AT, Blake PA, Jernigan DB, Holman RC, Lance-Parker SE, Chamberland ME, Kuehnert MJ.

Transfusion. 2004 Jul;44(7):967-72. Erratum in: Transfusion. 2004 Oct;44(10):1541.

PMID:
15225234
49.

Clostridium infections associated with musculoskeletal-tissue allografts.

Kainer MA, Linden JV, Whaley DN, Holmes HT, Jarvis WR, Jernigan DB, Archibald LK.

N Engl J Med. 2004 Jun 17;350(25):2564-71. Erratum in: N Engl J Med. 2004 Jul 22;351(4):397-8. N Engl J Med. 2004 Nov 4;351(19):2025.

50.

SARS in healthcare facilities, Toronto and Taiwan.

McDonald LC, Simor AE, Su IJ, Maloney S, Ofner M, Chen KT, Lando JF, McGeer A, Lee ML, Jernigan DB.

Emerg Infect Dis. 2004 May;10(5):777-81. Review.

Supplemental Content

Loading ...
Support Center